287840 — Intocell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Intocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	11,013	6,958	23,074
Net Total Accounts Receivable
Net Total Receivables	—	202	1,265	433
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0	17,403	13,495	31,294
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	3,596	3,343	3,280
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	—	25,943	23,711	41,254
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	—	10,702	13,508	3,223
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	—	12,716	16,190	16,504
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	—	13,227	7,521	24,749
Total Liabilities & Shareholders' Equity	—	25,943	23,711	41,254
Total Common Shares Outstanding